Shockwave Medical Completes Acquisition of Neovasc
11. April 2023 08:20 ET
|
Neovasc, Inc.
SANTA CLARA, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat...
Neovasc Shareholders Approve Acquisition by Shockwave Medical
06. März 2023 17:37 ET
|
Neovasc, Inc.
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices...
Neovasc Announces German Reimbursement Renewal
01. Februar 2023 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (“Neovasc” or “the Company”) (NASDAQ , TSX : NVCN) today announced the German Institute for the Hospital...
Neovasc Announces Progress on COSIRA-II Clinical Trial
28. November 2022 16:45 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical...
Neovasc Comments on European Heart Journal Publication
18. November 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case...
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
10. November 2022 16:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the third quarter...
Neovasc Provides Corporate Update Following Clinical Data Release
20. September 2022 09:05 ET
|
Neovasc, Inc.
New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the...
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
15. September 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today commented on the Centers for Medicare and...
Neovasc Announces Key Events at TCT 2022
08. September 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced its participation and presence at the...
Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
30. August 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Aug. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be...